Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 167-171

  Lazarevich, N L ^a   Shavochkina, D A ^a   Fleishman, D I ^a   Kustova, I F ^a   Morozova, O V ^a   Chuchuev, E S ^a   Patyutko, Y I ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Hepatocellular carcinoma; Hepatocyte nuclear factor

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTE NUCLEAR FACTOR 4ALPHA;

CARCINOGENESIS; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; EPITHELIUM TUMOR; HEPATITIS B; LIVER CELL CARCINOMA; METASTASIS; REVIEW; TUMOR GROWTH;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER NEOPLASMS;

EID: 77957724345     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Abelev GI, Lazarevich NL. Control of differentiation in progression of epithelial tumors. Adv Cancer Res 2006; 95: 61-113.
2. Zaret KS, Watts J, Xu J, et al. Pioneer factors, genetic competence, and inductive signaling: programming liver and pancreas progenitors from the endoderm. Cold Spring Harb Symp Quant Biol 2008; 73: 119-26.
3. Tronche F, Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 1992; 14: 579-87.
4. Locker J. Tissue-specific regulation by transcription factors. In: Locker J, ed. Transcription factors. Oxford: BIOS Sci Publ, 2001: 237-62.
5. Lazarevich NL, Fleishman DI. Tissue-specific transcription factors in progression of epithelial tumors. Biochemistry 2008; 73: 573-91.
6. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 271-85.
7. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Gen 2002; 31: 339-45.
8. Sladek FM, Seidel SD. Hepatocyte nuclear factor 4a. In: Burris TP, McCabe ERB, eds. Nuclear receptors and genetic disease. San Francisco: Academic Press, 2001: 309-361.
9. Thomas H, Jaschkowitz K, Bulman M, et al. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 2001; 10: 2089-97. (Pubitemid 32998821)
10. Torres-Padilla ME, Sladek FM, Weiss MC. Developmentally regulated N-terminal variants of the nuclear receptor Hepatocyte Nuclear Factor 4a mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J Biol Chem 2002; 277: 44677-87.
11. Jiang S, Tanaka T, Iwanari H, et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl Recept 2003; 1: 5. (Pubitemid 39130375)
12. Tanaka T, Jiang S, Hotta H, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4α in the pathogenesis of human cancer. J Pathol 2006; 208: 662-72.
13. Nammo T, Yamagata K, Tanaka T, et al. Expression of HNF-4a (MODY1), HNF-1b (MODY5), and HNF-1a (MODY3) proteins in the developing mouse pancreas. Gene Exp Patterns 2008; 8: 96-106.
14. Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4α. Genes Dev 2000; 14: 464-74.
15. Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis. Nat Gen 2003; 34: 292-6.
16. Gupta RK, Gao N, Gorski RK, et al. Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev 2007; 21: 756-69.
17. Garrison WD, Battle MA, Yang C, et al. Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology 2006; 130: 1207-20.
18. Lucas B, Grigo K, Erdmann S, et al. HNF4a reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 2005; 24: 6418-31. (Pubitemid 41486475)
19. Späth GF, Weiss MC. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 1998; 140: 935-46.
20. Lazarevich NL, Cheremnova OA, Varga EA, et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 2004; 39: 1038-47.
21. Fleishman DI, Morozova OV, Lazarevich NL. Tissue-specific gene expression in mouse hepatucarcinomas of different differentiation levels. Vestn RONC RAMN 2008; 19: 22-27 (In Russian).
22. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20: 1218-49.
23. Sipos B, Möser S, Kalthoff H, et al. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003; 442: 444-52. (Pubitemid 36718311)
24. Sel S, Ebert T, Ryffel GU, et al. Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4α and HNF1α. Cancer Lett 1996; 101: 205-10.
25. Schuster MB, Porse BT. C/EBPα: A tumour suppressor in multiple tissues? Biochim Biophys Acta 2006; 1766: 88-103.
26. Koschmieder S, Halmos B, Levantini E, et al. Dysregulation of the C/EBP alpha differentiation pathway in human cancer. J Clin Oncol 2009; 27: 619-28.